Approval Year
| Substance Class |
Concept
|
| Record UNII |
OJ72N0B4UC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OJ72N0B4UC
Created by
admin on Sat Dec 16 14:18:14 UTC 2023 , Edited by admin on Sat Dec 16 14:18:14 UTC 2023
|
PRIMARY | |||
|
C151952
Created by
admin on Sat Dec 16 14:18:14 UTC 2023 , Edited by admin on Sat Dec 16 14:18:14 UTC 2023
|
PRIMARY | NCIT |
This is a non-substance concept
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
Fc-glycans are homogenously engineered onto the antibody and increase ADCC, anti-tumor activity and the half-life of the antibody.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
This is a non-substance concept